Company profile
Hengsai Biological company profile
Hengsai Bio is a tumor immunotherapy developer that engages in R&D and industrialisation of a new generation dendritic cell tumor vaccines.
Business identity
- Website
- https://www.kousai.vip
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Shimenjie, Jiangxi, China
- Country code
- CN
- Continent
- Asia